Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
Paracetamol
Clonmel Healthcare Ltd
N02BE; N02BE01
Paracetamol
1000 milligram(s)
Suppository
Anilides; paracetamol
Marketed
2013-09-06
Page 1 of 5 PACKAGE LEAFLET: INFORMATION FOR THE USER TIPOL MAX 1000 MG SUPPOSITORIES PARACETAMOL FOR ADULTS AND CHILDREN OVER 12 YEARS OF AGE WITH A BODY WEIGHT OF 43 KG OR MORE READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to use Tipol Max carefully to get the best results from it. - Keep this leaflet. You may need to read it again. - Ask your pharmacist, if you need more information or advice. - You must contact a doctor if the symptoms worsen or do not improve after three days. - If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. - Contains paracetamol - Do not take any other paracetamol-containing products - Do not exceed the stated dose - Immediate medical advice should be sought in the event of overdosage, because of the risk of irreversible liver damage. IN THIS LEAFLET 1. What Tipol Max is and what it is used for 2. What you need to know before you use Tipol Max 3. How to use Tipol Max 4. Possible side effects 5. How to store Tipol Max 6. Contents of the pack and other information 1. WHAT TIPOL IS AND WHAT IT IS USED FOR Tipol Max contains paracetamol which belongs to a group of medicines known as analgesics. Paracetamol is a medicine that relieves pain and reduces fever. Tipol Max is used to treat: - mild to moderate pain and fever. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE TIPOL DO NOT USE TIPOL MAX - if you or your child are allergic (hypersensitive) to paracetamol, soya, or any of the other ingredients of Tipol Max (See section 6, Contents of the pack and other information). - If you or your child are allergic to soya or peanut (Tipol Max contains soya lecithin) - If your child is under 12 years of age or weighs less than 43 kilograms. - If you or your child have SEVERE LIVER PROBLEMS. TAKE SPECIAL CARE WITH TIPOL MAX SPEAK TO YOUR DOCTOR IF YOU OR YOUR CHILD HAVE: - moderate liver problems; - severe ki Lue koko asiakirja
Health Products Regulatory Authority 02 August 2022 CRN00CWPP Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Tipol Max 1000 mg suppositories 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains 1000 mg of paracetamol. Excipient(s) with known effect Contains soya lecithin (25 mg). For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Suppository. White to ivory coloured, odourless, torpedo-shaped suppository with an approximate length of 34 mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of mild to moderate pain and/or fever. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dose of paracetamol depends on the patient’s age and body weight. Details on the posology are available in the following table. The single dose is usually between 10 - 15 mg/kg body weight, to a maximum up to 60 mg/kg body weight for a total daily dose. The interval between doses depends on the symptomatology and the maximum daily dose. It should be at least six hours. If symptoms are persisting for more than three days medical attention must be received. BODY WEIGHT (AGE) SINGLE DOSE (EQUIVALENT DOSE OF PARACETAMOL) MAXIMUM DAILY DOSE (24 HOURS) (EQUIVALENT DOSE OF PARACETAMOL) more than 43 kg (Children from 12 years and adults) 1 suppository (equivalent to 1000 mg of paracetamol) 4 suppositories (equivalent to 4000 mg of paracetamol) The maximum daily dose (24 hours) must not be exceeded METHOD OF ADMINISTRATION Tipol Max suppositories should be put deeply into the rectum after bowel movement. They may be warmed up in the hands or dipped for a short time into warm water to improve their sliding properties. SPECIAL GROUPS OF PATIENTS Hepatic insufficiency and mild renal insufficiency For patients with impaired liver and kidney function or Gilbert´s syndrome the dose should be reduced or the interval between doses should be increased. Health Products Regulatory Authority 02 August 2022 CRN00CWPP Page 2 of 8 Severe renal insufficiency Severe renal insuf Lue koko asiakirja